机构：[1]Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China.首都医科大学附属北京同仁医院临床科室变态反应科[2]Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.临床科室耳鼻咽喉-头颈外科首都医科大学附属北京同仁医院首都医科大学附属同仁医院[3]Beijing Laboratory of Allergic Diseases and Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.首都医科大学附属北京同仁医院研究所耳鼻咽喉科研究所[4]Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases, Chinese Academy of Medical Sciences, Beijing, China.
National key R&D program of China, 2022YFC2504100. The program
for the Changjiang scholars and innovative research team,
IRT13082. CAMS innovation fund for medical sciences, 2019‐I2M‐5‐
022. Capital's funds for health improvement and research, 2022‐1‐
1091. Natural Science Foundation of China, 81970849, 82071022
and 82271141. Beijing Municipal Science & Technology Commission,
Z211100002921060.
第一作者机构：[1]Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China.[2]Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.[3]Beijing Laboratory of Allergic Diseases and Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.
共同第一作者：
通讯作者：
通讯机构：[1]Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China.[2]Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.[3]Beijing Laboratory of Allergic Diseases and Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.[4]Research Unit of Diagnosis and Treatment of Chronic Nasal Diseases, Chinese Academy of Medical Sciences, Beijing, China.[*1]Beijing Institute of Otolaryngology, No. 17, HouGouHuTong, DongCheng District, Beijing 100005, China[*2]Department of Allergy, Beijing Tongren Hospital, Capital Medical University, No. 1, Dongjiaominxiang, DongCheng District, Beijing 100730, China
推荐引用方式(GB/T 7714)：
Liu Dong,Li Jingyun,Gao Yunbo,et al.Clinical response to subcutaneous immunotherapy at 3 years in allergic rhinitis patients is predicted by short-term treatment effectiveness[J].CLINICAL AND TRANSLATIONAL ALLERGY.2023,13(2):doi:10.1002/clt2.12223.
APA：
Liu Dong,Li Jingyun,Gao Yunbo,Cao Feifei,Xiong Wei...&Zhang Luo.(2023).Clinical response to subcutaneous immunotherapy at 3 years in allergic rhinitis patients is predicted by short-term treatment effectiveness.CLINICAL AND TRANSLATIONAL ALLERGY,13,(2)
MLA：
Liu Dong,et al."Clinical response to subcutaneous immunotherapy at 3 years in allergic rhinitis patients is predicted by short-term treatment effectiveness".CLINICAL AND TRANSLATIONAL ALLERGY 13..2(2023)
